Important Safety Information

 

Last Updated: July 24, 2025

The injectable tirzepatide provided through BetterMe Rx is a compounded medication and is not manufactured by Eli Lilly, the maker of Zepbound® and Mounjaro®. This version is not FDA-approved and is not subject to the same regulatory standards as commercial products.

What Is Compounded Injectable Tirzepatide?

Compounded tirzepatide is prepared in response to a valid prescription by licensed U.S. pharmacies operating under Section 503A or 503B. It is generally formulated for subcutaneous injection and may be provided in multi-dose vials or pre-filled syringes.

Not FDA-Approved

This compounded medication has not been reviewed or approved by the FDA for safety, efficacy, or quality. BetterMe Rx makes no claims about equivalency with Zepbound®, Mounjaro®, or any FDA-approved product.

Medical Supervision Required

Use only under the supervision of a licensed medical professional. Potential side effects may include gastrointestinal distress, injection site irritation, fatigue, or serious conditions such as pancreatitis or thyroid tumors. Dosing, potency, and absorption may vary from commercial versions.

Fulfillment by Licensed Pharmacies

All prescriptions for compounded injectable tirzepatide are fulfilled by properly licensed compounding pharmacies that adhere to applicable state and federal regulations.